Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD

Y. Suzuki (Fukushima, Japan), J. Saito (Fukushima, Japan), M. Rikimaru (Fukushima, Japan), M. Uematsu (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), S. Sato (Fukushima, Japan), T. Kawamata (Fukushima, Japan), . Togawa (Fukushima, Japan), . Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), N. Fukuhara (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan)

Source: International Congress 2019 – Evaluation of basic science in airway diseases

Session: Evaluation of basic science in airway diseases
Session type: Poster Discussion
Number: 1707

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Suzuki (Fukushima, Japan), J. Saito (Fukushima, Japan), M. Rikimaru (Fukushima, Japan), M. Uematsu (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), S. Sato (Fukushima, Japan), T. Kawamata (Fukushima, Japan), . Togawa (Fukushima, Japan), . Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), N. Fukuhara (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan). Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD. 1707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Hydrogen sulfide (H₂S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
Clinical application of hydrogen sulfide (H2S) as a marker of asthma management Source: International Congress 2016 – Asthma points to ponder Year: 2016
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Monitoring exhaled carbon monoxide in COPD exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014
Exhaled breath condensate pH in assessment of childhood asthma control Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014
Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013
Endogenous hydrogen sulfide (H₂S) in serum and sputum as novel biomarker of asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014
Evaluation of hydrogen perioxide in breath condensate in children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013